Huang SM et al. |
Liquid chromatographic-mass spectrometric measurement of the endogenous cannabinoid 2-arachidonylglycerol in the spinal cord and peripheral nervous system. |
1999 |
Zhongguo Yao Li Xue Bao |
pmid:11189199
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Sugiura T and Waku K |
2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist. |
2001 |
World Rev Nutr Diet |
pmid:11935957
|
Kvasnicka T |
[The endocannabinoid system and interference with thrombogenesis]. |
2010 |
Vnitr Lek |
pmid:20329583
|
Fan SF and Yazulla S |
Retrograde endocannabinoid inhibition of goldfish retinal cones is mediated by 2-arachidonoyl glycerol. |
2007 May-Jun |
Vis. Neurosci. |
pmid:17592669
|
Keyshams N et al. |
Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer- type chicks: role of glutamate NMDA and AMPA receptors. |
2016 |
Vet. Res. Commun. |
pmid:27000110
|
Alizadeh A et al. |
Role of cannabinoidergic system on food intake in neonatal layer-type chicken. |
2015 |
Vet. Res. Commun. |
pmid:25902906
|
Di Marzo V and Maccarrone M |
FAAH and anandamide: is 2-AG really the odd one out? |
2008 |
Trends Pharmacol. Sci. |
pmid:18394720
|
Fowler CJ |
Has FLAT fallen flat? |
2014 |
Trends Pharmacol. Sci. |
pmid:24398120
|
Szallasi A and Di Marzo V |
New perspectives on enigmatic vanilloid receptors. |
2000 |
Trends Neurosci. |
pmid:11006466
|
Alhouayek M and Muccioli GG |
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. |
2012 |
Trends Mol Med |
pmid:22917662
|
Gaetani S et al. |
Anandamide hydrolysis: a new target for anti-anxiety drugs? |
2003 |
Trends Mol Med |
pmid:14604824
|
Mechoulam R et al. |
Cannabinoids and brain injury: therapeutic implications. |
2002 |
Trends Mol Med |
pmid:11815270
|
Reddy IA et al. |
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. |
2016 |
Transl Psychiatry |
pmid:27187231
|
Hartley ND et al. |
2-arachidonoylglycerol signaling impairs short-term fear extinction. |
2016 |
Transl Psychiatry |
pmid:26926885
|
Li B et al. |
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury From SO2 Inhalation via PPARγ Pathway. |
2015 |
Toxicol. Sci. |
pmid:26209559
|
Carr RL et al. |
Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats. |
2011 |
Toxicol. Sci. |
pmid:21507991
|
Carr RL et al. |
Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure. |
2013 |
Toxicol. Sci. |
pmid:23761300
|
Wu SY et al. |
Metabolomic assessment of arsenite toxicity and novel biomarker discovery in early development of zebrafish embryos. |
2018 |
Toxicol. Lett. |
pmid:29551592
|
Quistad GB et al. |
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. |
2006 |
Toxicol. Appl. Pharmacol. |
pmid:16310817
|